The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...

Sinus infections, also known as sinusitis, can leave us feeling miserable with symptoms like nasal congestion, facial pain ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved pharma major GSK’s Exdensur (depemokimab), the first twice-yearly biological medicine for use as an add-on treatment for ...

And for added relief from a stubborn stuffy nose, add a few drops of eucalyptus oil to the water and breathe in its scented ...

Small, persistent changes in the nose or face are easy to ignore, but in some cases they are the earliest signs of a much ...

The U.S. Food and Drug Administration has announced a nationwide recall of nasal spray, which officials report has been found ...

Health experts say a new H3N2 flu variant is spreading early this season. Learn symptoms, vaccine guidance and what to watch ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment of severe asthma characterised by an ...

I am a 68-year-old female who was first diagnosed with osteopenia and now osteoporosis. My physician has highly recommended ...